Blog and news
Practical, evidence-based articles on weight, health and everyday habits from the PharmaRoo team, plus news about our service. General information only: talk to your GP or a prescriber about your own situation.
Mounjaro vs Wegovy: how the two weight loss injections compare
Mounjaro (tirzepatide) vs Wegovy (semaglutide): how these weekly weight loss injections differ on mechanism, licensing and use. Educational guide, not medical advice.
Mounjaro vs Ozempic: what is the difference?
Mounjaro (tirzepatide) vs Ozempic (semaglutide): the key difference is licensing. Ozempic is licensed in the UK for type 2 diabetes, not weight loss. Educational guide.
Tirzepatide vs Semaglutide: the science compared
Tirzepatide vs semaglutide explained: tirzepatide is a dual GLP-1/GIP agonist, semaglutide is a single GLP-1 agonist. How the two weight loss medicines differ. Educational guide.
Retatrutide vs Tirzepatide (Mounjaro): triple vs dual agonist
Retatrutide vs tirzepatide (Mounjaro): retatrutide is an investigational triple agonist, tirzepatide a licensed dual agonist. How they differ and where retatrutide stands. Educational guide.